Deep Brain Stimulation Effects in Essential Tremor
1 other identifier
observational
4
1 country
1
Brief Summary
Deep Brain Stimulation (DBS) is an effective therapy for patients with medically refractory essential tremor. However, DBS programming is not standardized and multiple clinic visits are frequently required to adequately control symptoms. The investigators aim to longitudinally record brain signals from patients using a novel neurostimulator that can record brain signals. The investigators will correlate brain signals to clinical severity scores to identify pathological rhythms in the absence of DBS, and we will study the effects of DBS on these signals in order to guide clinical programming.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 6, 2020
CompletedFirst Posted
Study publicly available on registry
October 9, 2020
CompletedStudy Start
First participant enrolled
December 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2024
CompletedOctober 9, 2024
October 1, 2024
3.5 years
October 6, 2020
October 8, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Fahn- Tolosa- Marin Tremor Rating Scale
A clinical scale of tremor severity (0-4, 0:no symptoms, 4:extreme)
6 months
Study Arms (1)
Patients with essential tremor
Patients with essential tremor who have clinically been deemed candidates for DBS (Deep Brain Stimulation) surgery. Deep brain stimulation is an FDA approved therapy that involves surgical implantation of electrodes in deep brain targets and an implantable pulse generator delivers electrical pulses. This intervention is not part of the study. The investigators are going to recruit patients who receive the Medtronic Percept device, which allows for brain signal recordings (this feature is FDA approved). The investigators will be conducting an observational study using this device to collect data that the subjects receive as standard of care.
Eligibility Criteria
Patients with essential tremor, who have been cleared for DBS surgery.
You may qualify if:
- Patient gives an informed consent.
- Patient is over 21 years of age.
- Having a diagnosis of a essential tremor confirmed by a trained movement disorders neurologist;
- Having failed or not tolerated conventional medical management, at the discretion of the neurologist managing the patient;
You may not qualify if:
- Having alternative diagnoses to essential tremor;
- Having comorbid neurodegenerative disorders that may affect mobility or cognition (e.g. comorbid Parkinson's disease or dystonia);
- Having sequelae of prior brain insult (e.g. prior stroke or brain tumor);
- History of prior resective brain surgery (e.g. tumor resection);
- Not being a DBS candidate;
- Receiving unilateral implants
- Having a higher surgical risk that precludes patient from having standard intraoperative mapping.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Florida
Gainesville, Florida, 32611, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 6, 2020
First Posted
October 9, 2020
Study Start
December 5, 2020
Primary Completion
May 30, 2024
Study Completion
May 30, 2024
Last Updated
October 9, 2024
Record last verified: 2024-10